Increased vulnerability to oxidative stress and mitochondrial dysfunction in autism

The Molecular Basis of Autism

Volumn , Issue , 2015, Pages 407-425

  Chauhan, Abha ^a   Chauhan, Ved ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Antioxidants; Autism; Glutathione; Mitochondrial dysfunction; Oxidative stress

Indexed keywords

EID: 84944544807     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-2190-4_20     Document Type: Chapter

References (114)

1. Adams M, Lucock M, Stuart J, Fardell S, Baker K, Ng X (2007) Preliminary evidence for involvement of the folate gene polymorphism 19 bp deletion-DHFR in occurrence of autism. Neurosci Lett 422:24-29.
2. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011a) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) 8:34-66.
3. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011b) Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatrics 11:111-131.
4. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2013) Toxicological status of children with autism vs. neurotypical children and the association with autism severity. Biol Trace Elem Res 151:171-180.
5. Al-Farsi YM, Waly MI, Al-Sharbati MM, Al-Shafaee MA, Al-Farsi OA, Al-Khaduri MM, Gupta I, Ouhtit A, Al-Adawi S, Al-Said MF, Deth RC (2013) Levels of heavy metals and essential minerals in hair samples of children with autism in Oman: a case-control study. Biol Trace Elem Res 151:181-186.
6. Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L (2009) Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem 42:1032-1040.
7. Al-Yafee YA, Al-Ayadhi LY, Haq SH, El-Ansary AK (2011) Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol 11:139.
8. Ali A, Waly MI, Al-Farsi YM, Essa MM, Al-Sharbati MM, Deth RC (2011) Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochimica Polonica 58:547551.
9. Anitha A, Nakamura K, Thanseem I, Matsuzaki H, Miyachi T, Tsujii M, Iwata Y, Suzuki K, Sugiyama T, Mori N (2013) Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol 23:294-302.
10. Arnaud P, Gianazza E, Miribel L (1988) Ceruloplasmin. Methods Enzymol 163:441-452.
11. Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S (2013) Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 225:51-59.
12. Barja G (1999) Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J Bioenerg Biomembr 31:347-366.
13. Bertoglio K, James SJ, Deprey L, Brule N, Hendren RL (2010) Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med. 16:555-560.
14. Bertram R, Gram Pedersen M, Luciani DS, Sherman A (2006) A simplified model for mitochondrial ATP production. J Theor Biol. 243:575-586.
15. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9-19.
16. Bortolato M, Godar SC, Alzghoul L, Zhang J, Darling RD, Simpson KL, Bini V, Chen K, Wellman CL, Lin RC, Shih JC (2013) Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol 16:869-888.
17. Bowers K, Li Q, Bressler J, Avramopoulos D, Newschaffer C, Fallin MD (2011) Glutathione pathway gene variation and risk of autism spectrum disorders. J Neurodev Disord 3:132-143.
18. Brookes PS, Levonen AL, Shiva S, Sarti P, Darley-Usmar VM (2002) Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 33:755-764.
19. Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222-230.
20. Cadet J, Bellon S, Berger M, Bourdat AG, Douki T, Duarte V, Frelon S, Gasparutto D, Muller E, Ravanat JL, Sauvaigo S (2002) Recent aspects of oxidative DNA damage: guanine lesions, measurement and substrate specificity of DNA repair glycosylases. Biol Chem 383:933-943.
21. Chauhan A, Chauhan V (2006) Oxidative stress in autism. Pathophysiology 13:171-181.
22. Chauhan A, Chauhan V, Brown WT, Cohen I (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci 75:2539-2549.
23. Chauhan A, Chauhan V, Brown WT (eds) (2009a) Autism: oxidative stress, inflammation and immune abnormailities. CRC Press, Taylor and Francis Group, Florida, pp 1-427.
24. Chauhan A, Essa MM, Muthaiyah B, Brown WT, Chauhan V (2009b) Mitochondrial abnormalities in lymphoblasts from autism. J Neurochem 109 (Suppl. 1):273.
25. Chauhan A, Essa MM, Muthaiyah B, Brown WT, Wegiel J, Chauhan V (2010) Increased protein oxidation in cerebellum, frontal and temporal cortex in autism. International Meeting for Autism Research (Abstract).
26. Chauhan A, Audhya T, Chauhan V (2011a) Increased DNA oxidation in the cerebellum, frontal and temporal cortex of brain in autism. Trans Am Soc 42:81.
27. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V (2011b) Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 117:209-220.
28. Chauhan A, Audhya T, Chauhan V (2012a) Brain region-specific glutathione redox imbalance in autism. Neurochem Res 37:1681-1689.
29. Chauhan A, Gu F, Chauhan V (2012b) Mitochondrial respiratory chain defects in autism and other neurodevelopmental disorders. J Pediatr Biochem 2:213-223.
30. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, Holden JJ (2003) Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 64:190-197.
31. Cohen IL, Liu X, Lewis ME, Chudley A, Forster-Gibson C, Gonzalez M, Jenkins EC, Brown WT, Holden JJ (2011) Autism severity is associated with child and maternal MAOA genotypes. Clin Genet 79:355-362.
32. Davis LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J, Wassink TH (2008) Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet 147B:1145-1151.
33. Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M (2008) How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicology 29:190-201.
34. Distler MG, Palmer AA (2012) Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights. Front Genet 3:250-260.
35. Dupuy C, Virion A, Ohayon R, Kaniewski J, Deme D, Pommier J (1991) Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem 266:3739-3743.
36. Essa MM, Muthaiyah B, Chauhan V, Brown WT, Chauhan A (2009) Increased oxidative damage in lymphoblasts form autism: enhanced free radical generation coupled with reduced antioxidant status. J Neurochem 108 (Suppl 1):73.
37. Evans TA, Siedlak S, Lu L, Fu X, Wang Z, McGinnis W R, Fakhoury E, Castellani RJ, Hazen SL, Walsh WJ, Lewis AT, Salomon RG, Smith MA, Perry G, Zhu X (2008) The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am J Biochem Biotech 4:61-72.
38. Faber S, Zinn GM, Kern JC, 2nd, Kingston HM (2009) The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 14:171-180.
39. Fatemi SH, Cuadra AE, El-Fakahany EE, Sidwell RW, Thuras P (2000) Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11:1493-1496.
40. Fitzpatrick PF (2010) Oxidation of amines by flavoproteins. Arch Biochem Biophys 493:13-25.
41. Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, Bonassi S (2012) Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med 52:2128-2141.
42. Gargus JJ, Imtiaz F. (2008) Mitochondrial energy-deficient endophenotype in autism. Am J Biochem Biotech 4:198-207.
43. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR (2009) A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 34:386-393.
44. Granger DN (1988) Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 255:H1269-1275.
45. Gu F, Chauhan V, Chauhan A (2013a) Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes. Free Radic Biol Med 65:488-496.
46. Gu F, Chauhan V, Kaur K, Brown WT, Lafauci G, Wegiel J, Chauhan A (2013b) Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry 3:e299.
47. Guo T, Chen H, Liu B, Ji W, Yang C (2012) Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population. Genet Test Mol Biomarkers 16:968-973.
48. Gutteridge JM (1983) Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett 157:37-40.
49. Haas RH (2010) Autism and mitochondrial disease. Dev Disabil Res Rev 16:144-153.
50. Heinecke JW, Rosen H, Suzuki LA, Chait A (1987) The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 262:10098-10103.
51. Hibbs JB, Jr., Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87-94.
52. Hindley S, Juurlink BH, Gysbers JW, Middlemiss PJ, Herman MA, Rathbone MP (1997) Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res 47:427-439.
53. Holscher C, Rose SP (1992) An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett 145:165-167.
54. Hranilovic D, Bujas-Petkovic Z, Vragovic R, Vuk T, Hock K, Jernej B (2007) Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord 37:1934-1940.
55. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611-1617.
56. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 141B:947-956.
57. James SJ, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW (2008) Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J Autism Dev Disord 38:1966-1975.
58. James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O, Gaylor DW (2009) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 23:2374-2383
59. Jones BG, Rose FA, Tudball N (1994) Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 105:165-170.
60. Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK (2004) Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A. 131:11-17.
61. Juurlink BH, Paterson PG (1998) Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21:309-334.
62. Kaluzna-Czaplinska J, Michalska M, Rynkowski J (2011) Homocysteine level in urine of autistic and healthy children. Acta Biochim Pol 58:31-34.
63. Kellogg EW, 3rd, Fridovich I (1975) Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 250:8812-8817.
64. Kern JK, Jones AM (2006) Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9:485-499.
65. Kim HW, Cho SC, Kim JW, Cho IH, Kim SA, Park M, Cho EJ, Yoo HJ (2009) Family-based association study between NOS-I and -IIA polymorphisms and autism spectrum disorders in Korean trios. Am J Med Genet B Neuropsychiatr Genet 150B:300-306.
66. Lakshmi Priya MD Geetha A (2011) Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res 142:148-158.
67. Lenaz G (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52:159-164.
68. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal, Alzheimer’s disease, and Parkinson’s disease brain regions. J Neurochem 65:710-724.
69. Lonart G, Wang J, Johnson KM (1992) Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 220:271-272.
70. López-Hurtado E. Prieto JJ (2008) A microscopic study of language-related cortex in autism. Am J Biochem Biotech 4:130-145.
71. Lord C, Cook EH, Leventhal BL, Amaral DG (2000) Autism spectrum disorders. Neuron 28:355-363.
72. Main PA, Angley MT, O’Doherty CE, Thomas P, Fenech M (2012) The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab 9:35.
73. McGinnis WR (2004) Oxidative stress in autism. Altern Ther Health Med 10:22-36.
74. Meguid NA, Dardir AA, Abdel-Raouf ER, Hashish A (2011) Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res 143:58-65.
75. Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC (2005) Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 73:379-384.
76. Ming X, Johnson WG, Stenroos ES, Mars A, Lambert GH, Buyske S (2010) Genetic variant of glutathione peroxidase 1 in autism. Brain Dev 32:105-109.
77. Mohammad NS, Jain JM, Chintakindi KP, Singh RP, Naik U, Akella RR (2009) Aberrations in folate metabolic pathway and altered susceptibility to autism. Psychiatr Genet 19:171-176.
78. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM (2010) Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol 219:114-118.
79. Muller FL, Liu Y, Van Remmen H (2004) Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 279:49064-49073.
80. Muthaiyah B, Essa MM, Chauhan V, Brown WT, Wegiel J, Chauhan A (2009) Increased lipid peroxidation in cerebellum and temporal cortex of brain in autism. J Neurochem 108 (Suppl 1): 73.
81. Ozonoff S, Williams BJ, Landa R (2005) Parental report of the early development of children with regressive autism: the delays-plus-regression phenotype. Autism 9:461-486.
82. Palmieri L, Persico AM (2010) Mitochondrial dysfunction in autism spectrum disorders: cause or effect? Biochim Biophys Acta 1797:1130-1137.
83. Parellada M, Moreno C, Mac-Dowell K, Leza JC, Giraldez M, Bailon C, Castro C, Miranda-Azpiazu P, Fraguas D, Arango C (2012) Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res 46:394-401.
84. Pasca SP, Nemes B, Vlase L, Gagyi CE, Dronca E, Miu AC, Dronca M (2006) High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 78:2244-2248.
85. Pecorelli A, Leoncini S, De Felice C, Signorini C, Cerrone C, Valacchi G, Ciccoli L, Hayek J (2013) Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism. Brain Dev 35:146-154.
86. Polster BM, Fiskum G (2004) Mitochondrial mechanisms of neural cell apoptosis. J Neurochem 90:1281-1289.
87. Rehnstrom K, Ylisaukko-Oja T, Vanhala R, von Wendt L, Peltonen L, Hovatta I (2008) No association between common variants in glyoxalase 1 and autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 147B:124-127.
88. Roohi J, DeVincent CJ, Hatchwell E, Gadow KD (2009) Association of a monoamine oxidase-A gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord 39:67-74.
89. Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, James SJ (2012a) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2:e134.
90. Rose S, Melnyk S, Trusty TA, Pavliv O, Seidel L, Li J, Nick T, James SJ (2012b) Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Res Treat 2012:986519.
91. Rossignol DA, Frye RE (2012a) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17:290-314.
92. Rossignol DA, Frye RE (2012b) A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 17:389-401.
93. Russo AJ, Devito R (2011) Analysis of copper and zinc plasma concentration and the efficacy of zinc therapy in individuals with Asperger’s Syndrome, Pervasive developmental disorder not otherwise specified (PDD-NOS) and autism. Biomark Insights 6:127-133.
94. Sacco R, Papaleo V, Hager J, Rousseau F, Moessner R, Militerai R, Bravaccio C, Trillo S, Schneider C, Melmed R, Elia M, Curatolo P, Manzi B, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM (2007) Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. BMC Med Genet 8:11-20.
95. Sajdel-Sulkowska EM, Xu M, Koibuchi N (2009) Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 8:366-372.
96. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tassone F, Hertz-Picciotto I (2012) Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr 96:80-89.
97. Sogut S, Zoroglu SS, Ozyurt H, Yilmaz HR, Ozugurlu F, Sivasli E, Yetkin O, Yanik M, Tutkun H, Savas HA, Tarakcioglu M, Akyol O (2003) Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331:111-117.
98. Sutcliffe JS (2008) Genetics. Insights into the pathogenesis of autism. Science 321:208-209.
99. Sweeten TL, Posey DJ, Shankar S, McDougle CJ (2004) High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 55:434-437.
100. Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54:101-127.
101. Tang G, Gutierrez Rios P, Kuo SH, Akman O, Rosoklija G, Tanji K, Dwork A, Schon EA, Dimauro S, Goldman J, Sulzer D (2013) Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis 54:349-361.
102. Tassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto I (2011) MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res 4:250-261.
103. Thornalley PJ (2003) Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 31:1343-1348.
104. Tostes MH, Teixeira HC, Gattaz WF, Brandao MA, Raposo NR (2012) Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry 45:241-243.
105. Truman JW, De Vente J, Ball EE (1996) Nitric oxide-sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. Development 122:3949-3958.
106. Upchurch GR, Jr., Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Jr., Loscalzo J (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012-17017.
107. Williams TA, Mars AE, Buyske SG, Stenroos ES, Wang R, Factura-Santiago MF, Lambert GH, Johnson WG (2007) Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 161:356-361.
108. Wingate M, Kirby RS, Pettygrove S, Cunniff C, Schulz E, Ghosh T, Robinson C, Lee LC, Landa R, Constantino J, Fitzgerald R, Zahorodny W, Daniels J, Nicholas J, Charles J, McMahon W, Bilder D, Durkin M, Baio J, Christensen D, Braun KV, Clayton H, Goodman A, Doernberg N, Yeargin-Allsopp M, Lott E, Mancilla KC, Hudson A, Kast K, Jolly K, Chang A, Harrington R, Fitzgerald R, Shenouda J, Bell P, Kingsbury C, Bakian R, Henderson A, Arenson C, Washington A, Frenkel G, Wright V (2014) Prevalence of autism spectrum disorder among children aged 8 years autism and developmental disabilities monitoring network, 11 sites, United States, 20 I 0. MMWR Surveill Summ 63:1-21.
109. Wu YY, Chien WH, Huang YS, Gau SS, Chen CH (2008) Lack of evidence to support the glyoxalase 1 gene (GLO1) as a risk gene of autism in Han Chinese patients from Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 32:1740-1744.
110. Yoo HJ, Cho IH, Park M, Cho E, Cho SC, Kim BN, Kim JW, Kim SA (2008) Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios. Neurosci Res 62:66-69.
111. Yoo HJ, Lee SK, Park M, Cho IH, Hyun SH, Lee JC, Yang SY, Kim SA (2009) Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neurosci Res 63:172-176.
112. Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T (2002) Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67:341-343.
113. Zoroglu SS, Yurekli M, Meram I, Sogut S, Tutkun H, Yetkin O, Sivasli E, Savas HA, Yanik M, Herken H, Akyol O (2003) Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 21:55-60.
114. Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O, Meram I (2004) Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254:143-147.